Stage

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Stage

Property Description
Active Ingredient Rosuvastatin
Form Film-coated tablet
Pharmacological Class Statin (HMG-CoA reductase inhibitor)
Common Use Lipid-modifying therapy
Origin Synthetic compound

What Type of Medicine is Stage?

Stage is a synthetic medicinal product classified pharmacologically as an antihyperlipidemic agent and belongs to the statin class of drugs. This preparation is a single-ingredient pharmaceutical compound administered via the oral route, typically provided as a film-coated tablet. Rosuvastatin is a third-generation statin characterized by high efficacy within its class. This medicine belongs to a category of compounds used for lowering lipid levels.


Composition and General Purpose of Rosuvastatin

The active ingredient in Stage is Rosuvastatin, a chemically synthetic compound usually formulated as the calcium salt. Its defining mechanistic classification is that of an HMG-CoA reductase inhibitor. The general purpose of a Rosuvastatin-based drug is to facilitate lipid-modifying therapy, aiming to restore balance to the body's fat profile by reducing elevated levels of harmful lipids. This therapy is used in conditions requiring the reduction of elevated total cholesterol and low-density lipoprotein cholesterol.


The Essential Action of a Statin

The fundamental action of the statin class involves selectively targeting cholesterol synthesis within the body, primarily in the liver. This process works by blocking the HMG-CoA reductase enzyme, which is critical for the internal manufacturing of cholesterol. The consequence of this targeted action is a crucial general benefit: the simultaneous reduction of new cholesterol production and the accelerated removal of circulating "bad cholesterol," known as low-density lipoprotein (LDL) cholesterol, from the blood plasma.

Regulatory References

  1. National Center for Biotechnology Information (NIH)

What side effects are possible with Stage?

Possible side effects and safety information

The information below details the officially documented adverse effects and safety characteristics of Rosuvastatin (Stage), based strictly on government regulatory documents.


Documented Adverse Reactions by System and Frequency

Adverse reactions are classified by the organ system affected, based on regulatory standards. The most frequent adverse reactions, reported with an incidence rate of 2% or greater in clinical trials, include headache, nausea, constipation, and abdominal pain within the Gastrointestinal and Nervous Systems [1.2, 1.3]. Effects classified within the Musculoskeletal system, such as myalgia (muscle pain) and asthenia (physical weakness), are also listed among the most frequent reactions [1.2].

System-Organ Class Common Adverse Reactions
Musculoskeletal Myalgia, Asthenia
Nervous System Headache, Dizziness
Gastrointestinal Nausea, Constipation, Abdominal Pain

Serious Adverse Reactions and Safety Constraints

The official labeling outlines rare but serious adverse reactions related to muscle and liver function. These include myopathy (muscle weakness/pain) and rhabdomyolysis (severe muscle breakdown), which are documented to increase in risk at the highest approved dose and during treatment initiation [1.3]. Hepatic failure has also been reported as a rare, serious reaction [1.4, 2.2]. The medication is contraindicated in patients with active liver disease, severe renal impairment, and for women who are pregnant or breastfeeding [3.1].

Specific safety considerations are noted for geriatric patients (increased risk of muscle effects) and Asian patients (increased systemic exposure) [1.3, 3.4]. The risk of serious muscle complications also increases when Rosuvastatin is taken alongside certain other medications, such as Cyclosporine [1.3].

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents for rosuvastatin overdose strictly mandate immediate action and specific monitoring procedures. No specific clinical manifestations or characteristic symptoms are documented in the prescribing information resulting from acute overexposure.

If a suspected overdose occurs, it is officially mandated that the patient seek immediate medical attention or contact emergency medical services for immediate assessment.

Official Regulatory Findings in Overdose

Element Regulatory Statement
Documented Manifestations No specific symptoms are listed for acute overexposure in the clinical labeling.
Severe Risk Potential Rhabdomyolysis and subsequent acute renal failure are potential severe outcomes associated with the drug class, requiring clinical assessment.
Required Management Treatment must be symptomatic and supportive; no specific antidote is known.
Monitoring Needs Monitoring of liver function (transaminase levels) and Creatine Kinase (CK) levels is required for potential toxicity assessment.
Procedural Constraint Haemodialysis is not expected to be beneficial due to the extensive plasma protein binding of the active ingredient.

The required course of action focuses on immediate access to medical services for supportive care and clinical monitoring, particularly due to the systemic risks of muscular and renal injury associated with the statin class. This strict regulatory guidance on supportive care and mandated emergency seeking is the entirety of the official overdose profile.

Therapeutic Uses of Stage

What Stage Treats: Main Uses and Benefits

This medication is applied across therapeutic domains where short-term symptomatic assistance is needed and may assist with managing distressing physical manifestations that may interfere with comfort or functional stability.

This type of relief is commonly used to help with easing mild to moderate pain and reducing fever, and may be part of symptomatic management for conditions characterized by episodic or fluctuating symptom patterns.

It is primarily used in clinical settings that involve acute or unstable symptom patterns, often applied during phases when symptoms become more noticeable. It is considered relevant in contexts involving heightened systemic burden, where management of pain, fever, or discomfort is sought. A key benefit is that the treatment contributes to easing the overall symptom load and supports patients during episodes of heightened discomfort.

“In its application, this therapy is intended to help patients cope more steadily with symptom fluctuations during challenging episodes.”


Quick Facts

Quick Fact: Relief for Acute Symptomatic Episodes

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Stage (Rosuvastatin)

Eligibility to use Stage is strictly governed by regulatory classifications based on patient health status, age, and physiological factors.

Absolute Contraindications

Stage must not be used by patients with a known hypersensitivity to Rosuvastatin or any component. It is also absolutely contraindicated in individuals with active liver disease, defined as unexplained, persistent elevation of liver transaminase levels. Furthermore, the medicine is contraindicated in patients with existing myopathy (muscle disease) and those receiving concomitant Ciclosporin.

Reproductive and Age Eligibility

Category Regulatory Status
Pregnancy/Lactation Contraindicated in women who are pregnant or breastfeeding. Females of reproductive potential must use effective contraception.
Pediatric Use Approved for specific forms of familial hypercholesterolemia (HeFH) in children ge 8 years and (HoFH) in children ge 7 years. Use is not established in younger children.
Adult Use Approved for adults with primary hypercholesterolemia and mixed dyslipidemia.

Condition-Based Restrictions

Specific restrictions apply to patients with compromised organ function or other risk factors. The 40 mg dose is contraindicated in patients with moderate renal impairment (CrCl < 60 mL/min). In patients with severe renal impairment (CrCl < 30 mL/min), the maximum daily dose is limited to 10 mg. Patients of Asian descent are generally advised to start at a lower dose (5 mg) due to documented differences in systemic exposure.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Rosuvastatin is primarily structured around pharmacokinetic and pharmacodynamic constraints documented by regulatory authorities. The majority of clinically significant interactions occur due to inhibition of the OATP1B1 and BCRP drug transporters, rather than the cytochrome P450 enzyme system. This transporter inhibition by certain medicinal products leads to increased Rosuvastatin plasma exposure.

A formal additive risk of myopathy is documented with co-administration of Fibric Acid Derivatives (e.g., Gemfibrozil), Colchicine, and Niacin at lipid-modifying doses (ge 1 g/day). Regulatory labels specify that the combination with Gemfibrozil should be avoided. Certain herbal products, such as Red Yeast Rice, are also associated with this increased risk.

Combinations with Ciclosporin are strictly limited to the lowest dose or are considered contraindicated in some regions due to highly increased exposure. Several anti-viral agents are also subject to specific dose restrictions or are not recommended for co-administration.

To mitigate reduced absorption, Antacids containing aluminum or magnesium hydroxide must be administered at least two hours after Rosuvastatin. Additionally, the co-administration of Rosuvastatin with Coumarin Anticoagulants (e.g., Warfarin) requires frequent International Normalized Ratio (INR) monitoring due to the officially reported effect on coagulation. A lower starting dose is also noted for Asian patients due to documented higher systemic exposure.

Mechanism of Action

Stage acts through enzyme-mediated signaling that modulates the liver's cholesterol handling processes. Its mechanism is centered on two primary, consecutive physiological events: inhibiting internal cholesterol production and increasing the clearance of circulating cholesterol from the blood.


Targeted Inhibition of Hepatic Cholesterol Production

This domain covers the drug's interaction with its main biological target, the HMG-CoA reductase enzyme, which governs the Mevalonate pathway. By competitively inhibiting this enzyme, the drug blocks the key metabolic step, causing a deficit in the intracellular cholesterol pool within the liver cells (hepatocytes).


Compensatory Upregulation of LDL Receptors

The internal cholesterol deficit triggers a critical compensatory feedback loop: the significant upregulation of LDL receptors on the hepatocyte surface. This increased receptor density accelerates the removal (catabolism) of Low-Density Lipoprotein Cholesterol (LDL-C) from the blood plasma, which is the mechanism leading to an alteration of the systemic lipid equilibrium.


Non-Lipid Modulation of Vascular Pathways

Beyond its core lipid mechanism, the drug also affects the synthesis of isoprenoids, which influences subsequent vascular signaling pathways. This secondary mechanism, often termed pleiotropic, involves modulation of vascular signaling pathways that affect endothelial function and modulates certain markers of vascular inflammation, modifying biological activity within the circulatory system.

Dosage and Administration Information

How Rosuvastatin (Stage) is Used

Rosuvastatin is administered as a long-term, once-daily oral therapy for lipid management. This approach defines the standardized dosage, frequency, and administration conditions for the medicine.


Administration and Scheduling

Rosuvastatin is taken by the oral route using the film-coated tablet formulation. The dose is administered once daily and may be taken at any time of day, regardless of meals. The tablet must be swallowed whole and should not be crushed, dissolved, or chewed.

Dosing Regimens

The standard starting dose for adults is typically 10 mg or 20 mg once daily, with a general maintenance range spanning 5 mg to 40 mg. The maximum dose is 40 mg once daily, which is generally reserved for patients with severe hypercholesterolemia who do not achieve their target goal on lower doses.

Dosage adjustments, known as titration, are based on an assessment of the patient's lipid response and typically occur at intervals of four weeks or more after initiating therapy or changing the dose.


Population-Specific Use

Specific dosage considerations exist for certain populations. For instance, in patients of Asian descent, an initial dose of 5 mg once daily is recommended, and the maximum dose should usually not exceed 20 mg. For patients with severe kidney impairment who are not on hemodialysis, the starting dose should be 5 mg once daily and the dose should not exceed 10 mg per day.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Rosuvastatin (Stage)

Evidence for Managing High Cholesterol (Primary Hyperlipidemia)

The research into Rosuvastatin was initiated through short-term Randomized Controlled Trials (RCTs), as documented in regulatory product documentation. These studies primarily focused on adults with elevated levels of cholesterol, including specific subgroups with inherited conditions. Studies monitored the impact on key lipid markers in the blood, such as Low-Density Lipoprotein (LDL) Cholesterol (often referred to as "bad" cholesterol), total cholesterol, and triglycerides. Findings from these studies describe patterns observed in the changes measured in the patients' lipid profiles during the defined trial periods. However, the evidence gathered in these trials is focused on surrogate markers (laboratory values) rather than long-term clinical events.

Evidence for Preventing Major Cardiovascular Events (Primary Prevention)

The evidence relies heavily on large-scale, long-term, placebo-controlled RCTs. These studies evaluated outcomes in adults who did not yet have established cardiovascular disease (CVD) but were considered to be at an elevated risk. The primary outcomes monitored related to Major Adverse Cardiovascular Events (MACE), including nonfatal heart attack, nonfatal stroke, and cardiovascular death. The research describes the rates at which these events were observed in the study groups over multi-year follow-up periods. Despite the long duration, results for event prevention require long follow-up periods to accurately accrue data, and research does not determine whether an individual will respond similarly.

Evidence for Patients with Established Heart Disease (Secondary Prevention)

Research also explored outcomes in individuals who already have established heart conditions, such as Coronary Artery Disease. Studies often monitored the recurrence of MACE, and some research used specialized imaging techniques to measure changes in the volume and thickness of arterial plaque (atherosclerosis). While research is extensive, data are still limited for certain very specific types of fat disorders (dyslipidemias).


Evidence in Specific Patient Groups

Studies have been conducted to evaluate the medicine's use in specific populations, such as children and adolescents with Familial Hypercholesterolemia. These trials monitored the effect on lipid markers and standard metrics like growth and physical development. Research indicates that the measured short-term lipid shifts in children were documented by research to be consistent with patterns observed in adult trials. However, data for long-term cardiovascular outcomes remain limited due to the required long follow-up time. Research also included older adults and those with specific comorbidities who were observed in studies examining cardiovascular outcomes.

Frequently Asked Questions (FAQ)

Common questions about Stage (FAQ)

Q: Is Stage the same type of medicine as [similar drug name]? What's the difference?

Stage is classified as a statin, which is the general term for this class of medicine. It is considered a third-generation statin, meaning it belongs to a group of drugs used to modulate lipid levels. Official information focuses on its mechanism and use rather than direct product comparisons.


Q: Can Stage be used long-term?

Yes. According to the official product information, Stage is administered as a long-term oral therapy. Its purpose is to manage lipid levels over an extended period as part of an overall treatment plan.


Q: Are there any common over-the-counter medicines that interact with Stage?

Official regulatory information notes specific interactions with certain non-prescription products, such as specific antacids and some herbal supplements. Regulatory documents specify that antacids must be administered at least two hours after Stage to mitigate reduced absorption.


Q: Why do people sometimes stop taking Stage?

The primary reasons for discontinuation relate to the officially documented safety profile. Treatment may be stopped due to a patient having a contraindication (a reason not to take the drug), or the development of a serious adverse reaction concerning muscle or liver function.


Q: Is Stage safe for older adults (senior citizens)?

Official studies included older adults to evaluate the cardiovascular outcomes. However, regulatory documents specifically note that there is an increased risk of muscle effects in this population. The use in older adults is subject to specific safety considerations outlined in the product information.


Q: Does taking Stage with food change how it works?

No. Regulatory information indicates that Stage may be taken regardless of meals. This is because food does not significantly change how much of the medicine is absorbed into the body.


Q: What if I'm taking herbal supplements—do they interact with Stage?

Yes, some herbal products may interact. Official labeling specifies an additive risk of muscle effects when Stage is taken alongside certain herbal supplements, such as Red Yeast Rice. Official documentation requires healthcare providers to be informed about all concurrent supplements.


Q: What does 'contraindication' mean in relation to Stage?

A contraindication is a condition or factor described in official regulatory documents that makes the use of the medicine unadvised. It means that the risk of taking Stage under those circumstances is greater than any potential benefit.


Q: How does Stage fit into the overall treatment plan?

Stage is defined as a lipid-modifying therapy used to regulate cholesterol levels. It is typically a long-term therapy that requires ongoing monitoring of blood lipid levels. Dosage adjustments (titration) are made over time based on the patient's response.


Q: What are the general expectations about the outcome of treatment with Stage?

Regulatory documents confirm the medicine is used to reduce levels of harmful lipids (such as LDL-C) in the blood. Studies also confirm it is researched for its effect on reducing the risk of serious events like Major Adverse Cardiovascular Events (MACE).


Q: What is the difference between Stage and a placebo in clinical studies?

Clinical trials compare the effects of Stage against a placebo (an inactive substance). Research showed that the Stage group experienced observed changes in lipid markers and reductions in the rates of Major Adverse Cardiovascular Events compared to the placebo group.


Q: Will Stage definitely cure my condition?

No. Official documents describe Stage as a medicine used to manage lipid levels and reduce risks associated with high cholesterol. It is not described in regulatory documents as a cure for the underlying condition.


Q: What types of allergic reactions are listed for Stage?

Officially documented adverse reactions include cases of hypersensitivity reactions. These reactions may involve symptoms such as rash, itching, or swelling of the face, throat, or tongue (angioedema).


Q: Does Stage have any known interactions with grapefruit or other foods?

Official labeling does not specify an interaction between Stage and grapefruit juice or other common foods. However, this medicine may be affected by certain supplements like Red Yeast Rice.


Q: Is Stage a new or older drug?

Rosuvastatin is defined as a third-generation statin, a fact often cited in official reviews to describe its position within the class of lipid-modifying agents.


Q: Does Stage cause weight gain or weight loss?

Official regulatory adverse reaction lists do not commonly include weight gain or loss as one of the frequent side effects. Only reactions reported with an incidence rate of 2% or greater are typically listed as common.


Q: How long does it typically take for Stage to start working?

According to clinical pharmacology data, the maximum reduction in LDL-C (Low-Density Lipoprotein Cholesterol) is generally achieved within two to four weeks. This is typically after initiating therapy or adjusting the dose.


Q: What happens if I forget a dose of Stage?

Regulatory patient counseling material states that if a dose is missed, it is taken as soon as it is remembered. However, if the time is near the next scheduled dose, the missed dose is skipped to prevent taking two doses close together.


Q: Does Stage interact with alcohol?

Official warnings describe that use of the medicine is associated with caution in patients who consume substantial quantities of alcohol. This is due to the potential for an increased risk of serious liver and muscle problems.


Q: Can Stage affect my ability to drive or operate machinery?

Official labeling describes that the medicine is associated with side effects such as dizziness. This factor must be considered when determining fitness to drive or operate heavy machinery.


Q: Is Stage available as a generic medicine?

Yes. Regulatory databases confirm the active ingredient, Rosuvastatin, is available in generic formulations. These formulations are established through official drug approval processes.


Q: Are the side effects of Stage usually permanent?

Side effects are generally documented as events that occur during treatment. They are usually reversible upon discontinuation of the medicine. However, rare cases of severe injury (like hepatic failure) have been reported.


Q: Does Stage affect sleep?

Official adverse reaction documents have occasionally listed sleep-related issues. These may include insomnia (difficulty sleeping) or somnolence (drowsiness) among the less common side effects reported in clinical studies.


Q: What should I do if the side effects seem too strong?

Patient counseling documents specify that severe or unexplained symptoms, such as unexplained muscle pain or weakness, must be reported immediately to a healthcare provider for safety assessment.


Q: Does Stage have a 'Black Box Warning' (or similar official safety alert)?

No. While the most serious safety concerns are located in the Warnings and Precautions section, the medicine is officially documented to not carry an FDA Black Box Warning as of the most recent label update.


Q: Is Stage a narcotic or controlled substance?

No. Official regulatory classifications confirm that Stage (Rosuvastatin) is not classified as a narcotic or controlled substance. It is not associated with addiction potential or abuse risk.


Q: Does Stage cause any changes in mood or behavior?

Adverse reaction lists have occasionally reported psychiatric effects. These may include rare or uncommon observations of changes in mood or behavior, such as depression or anxiety, in clinical trials.


Q: What does the drug label mean by 'uncontrolled condition' in the contraindications section?

Regulatory documents specify conditions that are active or unexplained as reasons to prohibit the use of the medicine. Examples include active liver disease or unexplained persistent muscle enzyme elevations.


Q: Is it true that Stage works differently in men versus women?

Clinical pharmacology data generally do not indicate any clinically significant difference in the exposure or effect of the medicine between sexes. Therefore, no dosage adjustments are typically required based on sex.


Q: Does Stage affect my blood pressure or heart rate?

Adverse event lists have occasionally documented effects on the circulatory system. These have included reports of changes in blood pressure or palpitations as uncommon reactions in clinical studies.


Q: Do the official safety classifications for Stage mention addiction potential?

No. Official classifications confirm the medicine is not associated with addiction potential or abuse risk. It is not classified as a controlled substance.


Q: What are the general rules about stopping Stage treatment?

Patient guidance confirms that treatment termination is determined by a healthcare provider. Discontinuation can result in a rebound effect, which may lead to cholesterol levels increasing again.


Q: Can Stage be used by someone with diabetes?

Official warnings note that statins may cause an increase in HbA1c and fasting blood glucose levels. This factor is included in the regulatory precautions for patients with diabetes.

How should Stage be stored and disposed of?

How to Store and Dispose of Stage?

Stage must be stored under appropriate temperature and humidity conditions as defined in the official labeling to ensure the medicine retains its identity, strength, and purity. If no specific conditions are stated, the product is typically kept at controlled room temperature. The original container is designed to protect the medicine from light and moisture during storage.

All medicines must be stored out of sight and reach of children and pets in a secure location, with high-risk medicines requiring a locked cabinet. Do not store any medicine in areas where it may be subject to extreme heat, cold, or high humidity, such as the bathroom.

For disposal, the preferred method is a drug take-back or mail-back program where available. Medicines should not be thrown in household trash or flushed down the toilet unless specific instructions in the product information authorize it. Disposal must follow all local regulations for non-reclaimable pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Stage found in:

A-Z Index: